EV/EBITDA
-7.09
+0.52+6.83%
7 min ago
Summary
- As of March 12, 2025, IMVT EV/EBITDA is -7.09, with a rise of +0.52 (+6.83%) during the most recent trading day.
- Over the past year, IMVT EV/EBITDA has increased by +7.12 (+50.11%).
- IMVT EV/EBITDA is now -1225.40% below its all-time high of 0.63.
Performance
IMVT EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
IMVT EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +6.8% | -6.9% | -6.1% |
| 1 m1 month | +0.7% | -0.7% | -0.6% |
| 3 m3 months | +31.3% | -21.1% | -31.8% |
| 6 m6 months | +42.4% | -21.8% | -33.9% |
| ytdytd | +13.6% | -13.6% | -24.0% |
| 1 y1 year | +50.1% | -25.2% | -37.9% |
| 5 y5 years | +86.8% | +371.3% | +42.5% |
IMVT EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | -8.11 | +12.6% | |
| 3 m | 3-month | -7.09 | at high | -10.70 | +33.7% |
| 6 m | 6-month | -7.09 | at high | -13.09 | +45.8% |
| 1 y | 1-year | -7.09 | at high | -15.37 | +53.9% |
| 3 y | 3-year | 0.63 | -1225.4% | -24.97 | +71.6% |
| 5 y | 5-year | 0.63 | -1225.4% | -69.71 | +89.8% |
| alltime | all time | 0.63 | -1225.4% | -358 K | +100.0% |
Immunovant EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -7.09(-13.6%) |
| 2024 | -8.21(-61.6%) |
| 2023 | -21.40(+115.7%) |
| Date | Value |
|---|---|
| 2022 | -9.92(+198.8%) |
| 2021 | -3.32(-91.9%) |
| 2020 | -41.17(-37.3%) |
| 2019 | -65.64 |
FAQ
- What is Immunovant EV/EBITDA?
- What is the all time high EV/EBITDA for Immunovant?
- What is IMVT EV/EBITDA year-to-date change?
- What is Immunovant EV/EBITDA year-on-year change?
What is Immunovant EV/EBITDA?
The current EV/EBITDA of IMVT is -7.09
What is the all time high EV/EBITDA for Immunovant?
Immunovant all-time high EV/EBITDA is 0.63
What is IMVT EV/EBITDA year-to-date change?
Immunovant EV/EBITDA has changed by +1.12 (+13.64%) since the beginning of the year
What is Immunovant EV/EBITDA year-on-year change?
Over the past year, IMVT EV/EBITDA has changed by +7.12 (+50.11%)